Actinium Pharmaceuticals IncNYSE American:ATNM
- LAST PRICE7.4000
- TODAY'S CHANGE (%)0.0100 (0.1353%)
- Bid / Lots7.0100/ 67
- Ask / Lots8.1200/ 1
- Open / Previous Close7.3300 / 7.3900
- Day Range
- 52 Week Range
- Volume960,288
Search Criteria
Filter search criteria using below inputs
Click on magnifying glass icon to search
| Company | Country | Symbol |
|---|
- TSX Comp
- TSX Venture
- DJIA
- S&P 500
- NASDAQ
| Time | Volume | ATNM |
|---|---|---|
| 09:32 ET | 5848 | 7.33 |
| 09:43 ET | 8289 | 7.27 |
| 09:45 ET | 1428 | 7.24 |
| 09:48 ET | 1180 | 7.185 |
| 09:50 ET | 100 | 7.22 |
| 09:54 ET | 150 | 7.22 |
| 09:56 ET | 750 | 7.27 |
| 10:03 ET | 100 | 7.26 |
| 10:06 ET | 1758 | 7.29 |
| 10:10 ET | 1396 | 7.35 |
| 10:14 ET | 100 | 7.395 |
| 10:17 ET | 400 | 7.3896 |
| 10:21 ET | 300 | 7.36 |
| 10:24 ET | 100 | 7.36 |
| 10:26 ET | 2000 | 7.35 |
| 10:28 ET | 200 | 7.31 |
| 10:30 ET | 100 | 7.29 |
| 10:32 ET | 255 | 7.29 |
| 10:33 ET | 300 | 7.26 |
| 10:35 ET | 100 | 7.23 |
| 10:37 ET | 2099 | 7.265 |
| 10:39 ET | 438 | 7.18 |
| 10:44 ET | 1000 | 7.17 |
| 10:46 ET | 1825 | 7.2 |
| 10:53 ET | 300 | 7.23 |
| 10:55 ET | 2300 | 7.2 |
| 11:09 ET | 100 | 7.22 |
| 11:11 ET | 1800 | 7.15 |
| 11:15 ET | 500 | 7.13 |
| 11:18 ET | 200 | 7.14 |
| 11:22 ET | 3160 | 7.17 |
| 11:24 ET | 100 | 7.16 |
| 11:26 ET | 1075 | 7.16 |
| 11:29 ET | 100 | 7.15 |
| 11:31 ET | 2161 | 7.14 |
| 11:33 ET | 600 | 7.14 |
| 11:36 ET | 100 | 7.14 |
| 11:40 ET | 700 | 7.18 |
| 11:42 ET | 700 | 7.1642 |
| 11:44 ET | 613 | 7.14 |
| 11:45 ET | 100 | 7.14 |
| 11:49 ET | 663 | 7.147 |
| 11:51 ET | 300 | 7.17 |
| 11:56 ET | 150 | 7.1633 |
| 11:58 ET | 200 | 7.2 |
| 12:02 ET | 964 | 7.21 |
| 12:09 ET | 1022 | 7.2137 |
| 12:12 ET | 500 | 7.2168 |
| 12:18 ET | 200 | 7.23 |
| 12:23 ET | 100 | 7.25 |
| 12:27 ET | 1800 | 7.28 |
| 12:30 ET | 100 | 7.285 |
| 12:32 ET | 3700 | 7.24 |
| 12:36 ET | 100 | 7.24 |
| 12:39 ET | 100 | 7.225 |
| 12:41 ET | 100 | 7.23 |
| 12:48 ET | 350 | 7.22 |
| 12:50 ET | 100 | 7.18 |
| 12:52 ET | 100 | 7.19 |
| 12:54 ET | 100 | 7.205 |
| 12:59 ET | 100 | 7.21 |
| 01:08 ET | 100 | 7.21 |
| 01:10 ET | 100 | 7.22 |
| 01:14 ET | 100 | 7.22 |
| 01:21 ET | 100 | 7.19 |
| 01:24 ET | 518 | 7.19 |
| 01:26 ET | 3790 | 7.11 |
| 01:28 ET | 3575 | 7.16 |
| 01:30 ET | 465 | 7.1 |
| 01:32 ET | 3410 | 7.09 |
| 01:33 ET | 400 | 7.05 |
| 01:35 ET | 918 | 7.02 |
| 01:37 ET | 968 | 7.02 |
| 01:39 ET | 1975 | 7.02 |
| 01:42 ET | 100 | 7.025 |
| 01:44 ET | 1000 | 7.02 |
| 01:46 ET | 1100 | 7.0234 |
| 01:48 ET | 100 | 7.02 |
| 01:50 ET | 1165 | 7.04 |
| 01:51 ET | 1240 | 7.03 |
| 01:53 ET | 887 | 7.03 |
| 01:55 ET | 1059 | 7.05 |
| 02:00 ET | 100 | 7.055 |
| 02:04 ET | 100 | 7.055 |
| 02:06 ET | 200 | 7.07 |
| 02:08 ET | 200 | 7.065 |
| 02:11 ET | 100 | 7.065 |
| 02:13 ET | 500 | 7.09 |
| 02:15 ET | 500 | 7.09 |
| 02:18 ET | 1365 | 7.0801 |
| 02:20 ET | 800 | 7.11 |
| 02:22 ET | 1000 | 7.1 |
| 02:24 ET | 200 | 7.105 |
| 02:26 ET | 300 | 7.105 |
| 02:29 ET | 200 | 7.1 |
| 02:31 ET | 200 | 7.07 |
| 02:33 ET | 100 | 7.1 |
| 02:36 ET | 220 | 7.08 |
| 02:38 ET | 1652 | 7.06 |
| 02:42 ET | 500 | 7.085 |
| 02:45 ET | 300 | 7.06 |
| 02:47 ET | 128 | 7.085 |
| 02:49 ET | 900 | 7.06 |
| 02:54 ET | 100 | 7.0975 |
| 02:58 ET | 100 | 7.085 |
| 03:00 ET | 2430 | 7.095 |
| 03:02 ET | 500 | 7.12 |
| 03:03 ET | 3900 | 7.125 |
| 03:05 ET | 2000 | 7.12 |
| 03:07 ET | 1200 | 7.09 |
| 03:09 ET | 3011 | 7.14 |
| 03:12 ET | 1500 | 7.19 |
| 03:14 ET | 600 | 7.165 |
| 03:16 ET | 200 | 7.19 |
| 03:18 ET | 900 | 7.19 |
| 03:20 ET | 200 | 7.165 |
| 03:21 ET | 200 | 7.165 |
| 03:23 ET | 500 | 7.165 |
| 03:25 ET | 3230 | 7.15 |
| 03:27 ET | 100 | 7.14 |
| 03:30 ET | 100 | 7.14 |
| 03:32 ET | 7516 | 7.215 |
| 03:34 ET | 300 | 7.215 |
| 03:36 ET | 900 | 7.2275 |
| 03:38 ET | 200 | 7.215 |
| 03:39 ET | 2064 | 7.23 |
| 03:41 ET | 11080 | 7.3 |
| 03:43 ET | 701 | 7.285 |
| 03:45 ET | 1024 | 7.27 |
| 03:48 ET | 2420 | 7.28 |
| 03:50 ET | 24245 | 7.41 |
| 03:52 ET | 780 | 7.385 |
| 03:54 ET | 500 | 7.325 |
| 03:56 ET | 2380 | 7.36 |
| 03:57 ET | 5383 | 7.38 |
| 03:59 ET | 6360 | 7.4 |
Jun 18, 2024
Treatment of Blood Cancers - Biopharma Companies Building out their Pipeline of Solutions, from 8:46AM ET on Tuesday Jun 18, 2024 by Dow Jones
8:46AM ET on Tuesday Jun 18, 2024 by Dow Jones
Jun 17, 2024
DJ Actinium Pharmaceuticals Price Target Maintained With a $50.00/Share by HC Wainwright & Co., from 10:55AM ET on Monday Jun 17, 2024 by Dow Jones
10:55AM ET on Monday Jun 17, 2024 by Dow JonesAcute Myeloid Leukemia Market Size Expected to Reach $2.97 Billion By 2029 as Clinical Trials Increase, from 9:45AM ET on Monday Jun 17, 2024 by Dow Jones
9:45AM ET on Monday Jun 17, 2024 by Dow JonesAcute Myeloid Leukemia is on the Rise as Biotechs Race to Develop Groundbreaking Therapies, from 9:00AM ET on Monday Jun 17, 2024 by Dow Jones
9:00AM ET on Monday Jun 17, 2024 by Dow JonesBiopharma Stocks Quest for Solutions for Acute Myeloid Leukemia (AML), from 8:46AM ET on Monday Jun 17, 2024 by Dow Jones
8:46AM ET on Monday Jun 17, 2024 by Dow Jones
| Company sortable | Market Cap sortable | P/E Ratio (TTM) sortable | EPS Growth (5yr) sortable |
|---|---|---|---|
Actinium Pharmaceuticals Inc | 220.4M | -4.3x | --- |
Rezolute Inc | 220.9M | -3.8x | --- |
Greenwich Lifesciences Inc | 222.3M | -24.0x | --- |
Zura Bio Ltd | 222.9M | -2.1x | --- |
Solid Biosciences Inc | 217.6M | -1.4x | --- |
ATAI Life Sciences NV | 222.7M | -5.5x | --- |
Company Information
Actinium Pharmaceuticals, Inc. is a late-stage biopharmaceutical company. The Company is engaged in developing targeted radiotherapies to improve survival for people who have failed existing oncology therapies. The Company’s advanced pipeline candidates include Iomab-B (pre-BLA & MAA (EU)) and Actimab-A. Iomab-B is an induction and conditioning agent prior to bone marrow transplant. Actimab-A is a therapeutic agent, have demonstrated potential to extend survival outcomes for people with relapsed and refractory acute myeloid leukemia. The Company focuses on advance Iomab-B for other blood cancers and next generation conditioning candidate Iomab-ACT to improve cell and gene therapy outcomes. The Company holds patent applications including several patents related to the manufacture of the isotope Ac-225 in a cyclotron. Actinium-225 is a potent alpha-particle emitter that has high linear energy transfer capable of killing targeted cancer cells via double-strand breaks in DNA.
Contact Information
- Headquarters
- 100 Park Ave., 23Rd FloorNEW YORK, NY, United States 10017
- Phone
- 646-677-3870
- Fax
- 845-818-3588
Executives
- Chairman of the Board, Chief Executive Officer
- Sandesh Seth
- Chief Financial Officer
- Steve O'Loughlin
- Chief Business Officer
- Lynn Bodarky
- Independent Director
- Jeffrey Chell
- Lead Independent Director
- C. David Nicholson
Our Ratings feature offers company-specific research ratings from providers such as First Call, S&P and Argus.
Open a New Account, or Login if you're a client.
You have access to a comprehensive selection of independent research reports from providers such as TD Securities, S&P, INK, and Argus.
Open a New Account, or Login if you're a client.
Market Cap | $220.4M |
|---|---|
Revenue (TTM) | $81.0K |
Shares Outstanding | 29.8M |
Dividend Yield | 0.00% |
Annual Dividend Rate | --- |
Ex-Dividend Date | 01-01-01 |
Pay Date | 01-01-01 |
Beta | 0.20 |
EPS | $-1.72 |
Book Value | $1.32 |
P/E Ratio | -4.3x |
Price/Sales (TTM) | 2,721.0 |
Price/Cash Flow (TTM) | --- |
Operating Margin | -61,645.68% |
Our Calendar feature allows you to view a wide selection of market and company events, including earnings, dividends, splits, rating changes, guidance, and more. Access past, current and future events in WebBroker.
Open a New Account, or Login if you're a client.
